TY - JOUR
T1 - Three-dimensional echocardiography for predicting mitral stenosis after MitraClip for functional mitral regurgitation
AU - Kato, Yuta
AU - Okada, Atsushi
AU - Amaki, Makoto
AU - Nishimura, Kunihiro
AU - Kanzaki, Hideaki
AU - Kataoka, Yu
AU - Miyamoto, Koji
AU - Hamatani, Yasuhiro
AU - Amano, Masashi
AU - Takahama, Hiroyuki
AU - Hasegawa, Takuya
AU - Kusano, Kengo
AU - Fujita, Tomoyuki
AU - Kobayashi, Junjiro
AU - Yasuda, Satoshi
AU - Izumi, Chisato
N1 - Funding Information:
Atsushi Okada has received honoraria from Pfizer Inc., Daiichi Sankyo Co. Ltd., Alnylam Inc., Otsuka Pharmaceutical Co. Ltd., and research funding from Novartis. Makoto Amaki has received honoraria and manuscript fees from Abbott Medical. Hiroyuki Takahama has received honoraria from Novartis and Ono Pharmaceutical Co. Ltd. Kengo Kusano has received honoraria from Medtronic Japan Co. Ltd., Daiichi Sankyo Co. Ltd., Bristol-Myers Squibb Co., Bayer Yakuhin Ltd., Boston Scientific Co., and research funding from EP-CRSU Co. Ltd. Satoshi Yasuda has received research funding from Abbott Japan and Takeda Pharmaceutical Co. Ltd. Yuta Kato, Kunihiro Nishimura, Hideaki Kanzaki, Yu Kataoka, Koji Miyamoto, Yasuhiro Hamatani, Masashi Amano, Takuya Hasegawa, Tomoyuki Fujita, Junjiro Kobayashi and Chisato Izumi declare that they have no conflict of interest.
Publisher Copyright:
© 2022, Japanese Society of Echocardiography.
PY - 2022/9
Y1 - 2022/9
N2 - Background: Postprocedural mitral stenosis (MS), or increased transmitral mean pressure gradient (TMPG), is one of the limitations of transcatheter edge-to-edge mitral valve repair using MitraClip (Abbott Vascular Inc., Santa Clara, USA); however, the usefulness of three-dimensional transesophageal echocardiography (3D-TEE) for predicting postprocedural MS in functional mitral regurgitation (MR) has not been fully elucidated. Methods: Eighty-two consecutive functional MR patients who underwent transcatheter mitral valve repair using MitraClip were retrospectively studied. Postprocedural MS was defined as TMPG ≥ 5 mmHg by echocardiography. Results: Ten patients had postprocedural MS, and 3D-TEE showed that patients with postprocedural MS had smaller preprocedural mitral valve orifice area (MVOA), anteroposterior and mediolateral diameter, leaflet area, and annulus area. Receiver operating characteristic analysis showed that leaflet area (area under the curve (AUC) 0.829), annulus area (AUC 0.813), anteroposterior diameter (AUC 0.797) and mediolateral diameter (AUC 0.803) evaluated using 3D-TEE were predictors of postprocedural MS, and their predictive abilities were higher than those of preprocedural MVOA (AUC 0.756) and preprocedural TMPG (AUC 0.716). Adding leaflet area to TMPG and MVOA resulted in higher C-statistics for predicting postprocedural MS (from 0.716 to 0.845 and from 0.756 to 0.853, respectively). Conclusions: In functional MR patients treated with MitraClip, leaflet area and annulus area evaluated using 3D-TEE had high predictive values for postprocedural MS, and their predictive abilities were higher than those of preprocedural TMPG or MVOA.
AB - Background: Postprocedural mitral stenosis (MS), or increased transmitral mean pressure gradient (TMPG), is one of the limitations of transcatheter edge-to-edge mitral valve repair using MitraClip (Abbott Vascular Inc., Santa Clara, USA); however, the usefulness of three-dimensional transesophageal echocardiography (3D-TEE) for predicting postprocedural MS in functional mitral regurgitation (MR) has not been fully elucidated. Methods: Eighty-two consecutive functional MR patients who underwent transcatheter mitral valve repair using MitraClip were retrospectively studied. Postprocedural MS was defined as TMPG ≥ 5 mmHg by echocardiography. Results: Ten patients had postprocedural MS, and 3D-TEE showed that patients with postprocedural MS had smaller preprocedural mitral valve orifice area (MVOA), anteroposterior and mediolateral diameter, leaflet area, and annulus area. Receiver operating characteristic analysis showed that leaflet area (area under the curve (AUC) 0.829), annulus area (AUC 0.813), anteroposterior diameter (AUC 0.797) and mediolateral diameter (AUC 0.803) evaluated using 3D-TEE were predictors of postprocedural MS, and their predictive abilities were higher than those of preprocedural MVOA (AUC 0.756) and preprocedural TMPG (AUC 0.716). Adding leaflet area to TMPG and MVOA resulted in higher C-statistics for predicting postprocedural MS (from 0.716 to 0.845 and from 0.756 to 0.853, respectively). Conclusions: In functional MR patients treated with MitraClip, leaflet area and annulus area evaluated using 3D-TEE had high predictive values for postprocedural MS, and their predictive abilities were higher than those of preprocedural TMPG or MVOA.
KW - 3-dimensional transesophageal echocardiography (3D-TEE)
KW - Atrial functional mitral regurgitation
KW - MitraClip
KW - Mitral stenosis
KW - Predictor
KW - Ventricular functional mitral regurgitation
UR - http://www.scopus.com/inward/record.url?scp=85123955411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123955411&partnerID=8YFLogxK
U2 - 10.1007/s12574-022-00564-x
DO - 10.1007/s12574-022-00564-x
M3 - Article
C2 - 35084686
AN - SCOPUS:85123955411
SN - 1349-0222
VL - 20
SP - 151
EP - 158
JO - Journal of Echocardiography
JF - Journal of Echocardiography
IS - 3
ER -